EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
30.3%
Female
69.7%
Male
Age Information
The average age of patients reporting adverse events with EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL is 46.5 years.
Geographic Distribution
The majority of adverse event reports for EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL originate from US.
Report Summary & Outcomes
7,225
Total Reports
7,225
As Primary/Secondary Suspect
141
Deaths Reported
535
Hospitalizations
46
Life-Threatening
34
Disabilities
Reporting Timeline
First adverse event report: 199601. Most recent report: 20250513. View full timeline →